Xeris Pharmaceuticals, Inc.
180 N. Lasalle Street, Suite 1600
Chicago, IL  60601


Xeris Pharmaceuticals, Inc., the maker of Gvoke Hypopen®, is dedicated to unlocking the potential of glucagon. We believe that easier-to-use medicines can have a profound impact on the lives of patients and their families. That is why our first products to market are liquid glucagon, but that is just the beginning. We are also studying how our formulation technology can impact patients with other conditions. We have a persistent drive to pursue advancements that have the potential to change lives. Get to know us and see how our technology is unlocking the potential of today’s medicines at www.xerispharma.com.

Corporate Partner Level
Strategic Partner